Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Tenecteplase 50 Mg Iv Inj[cdh] (CDM 4001726) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/4001726/by-state?code_type=CDM
“Tenecteplase 50 Mg Iv Inj[cdh] (CDM 4001726) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4001726/by-state?code_type=CDM. Accessed
June 28, 2026 .
“Tenecteplase 50 Mg Iv Inj[cdh] (CDM 4001726) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/4001726/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4001726 — Tenecteplase 50 Mg IV Inj[cdh]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$10,641
National median
$10,134 – $18,356
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4001726 (CDM), with interquartile range
State Median p25 p75
NE $10,641 $10,134 $18,356